Director/PDMR Shareholding
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, announces the transfer of shares by a non-executive director ("PDMR").
The Company's total issued ordinary share capital is 257,927,489 shares, 18,506,177 shares of which are held in treasury by the Company.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | John LaMattina, PhD |
| 2 | Reason for the notification | |
| a) | Position/status | Non-Executive Director |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| b) | Nature of the transaction | The transferred shares were held in a charitable trust over which Dr. LaMattina has control. Dr. LaMattina periodically transfers shares from this trust to his alma mater, Boston College, as a form of support. |
| c) | Price(s) and volume(s) | Individual Price Volume John LaMattina Nil 52,640 |
| e) | Date of the transaction | 29 October 2024 |
| f) | Place of the transaction | Outside of a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.